Lonza | Resultat Før Skat



Pre Tax Profit Lave om Dato
Akzo Nobel EUR 169M 78M 2024-12
Alcon AG USD 349M 112M 2024-12
Almirall EUR 15.17M 72K 2024-06
AstraZeneca USD 1.67B 162M 2024-12
BASF EUR 565M 167M 2024-09
Bayer EUR -481000000 805M 2024-12
Beiersdorf EUR 864M 451M 2024-06
Covestro EUR 52M 0 2024-09
Demant DKK 967M 76M 2024-12
Fresenius EUR 401M 14M 2024-12
Fresenius Medical Care EUR 179.93M 201.07M 2024-12
Geberit CHF 188.3M 10.5M 2024-09
Genmab DKK 3.6B 1.88B 2024-12
Givaudan CHF 350M 166M 2024-06
GlaxoSmithKline GBP 563M 2.08B 2024-12
GN Store Nord DKK 21M 350M 2024-12
Hikma Pharmaceutical USD 144M 144M 2024-06
Johnson Matthey GBP 277M 236M 2024-09
Merck EUR 1.23B 449.38M 2024-09
Novartis USD 4.66B 269M 2024-12
Philips EUR 246M 411M 2024-09
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 2.18B 1.33B 2024-12
Sika AG CHF 372.05M 398.25M 2024-06
Smith & Nephew 399M 165M 2024-06
Solvay EUR 41M 12M 2024-12
UCB EUR 123M 464.07M 2024-06



Lonza Resultat Før Skat - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.